EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells

1 Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes Journal of Clinical Oncology, June 10, 2013

2 Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma Leukemia and Lymphoma, May 20, 2013

3 Dasatinib in children and adolescents with relapsed or refractory leukemia Journal of Clinical Oncology, May 30, 2013

4 Birth folate and childhood leukemia risk Cancer Epidemiology, Biomarkers & Prevention, May 22, 2013

5 CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia Leukemia, May 22, 2013

6 Solar UV radiation and cancer in young children Cancer Epidemiology, Biomarkers & Prevention, May 20, 2013

7 Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia Core Evidence, May 23, 2013

8 Impact of serum adiponectin and leptin levels in acute leukemia Hematology, May 23, 2013

9 Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib a retrospective chart review analysis Current Medical Research and Opinion, May 20, 2013    Review Article

10 Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma Leukemia, May 29, 2013